Results 201 to 210 of about 19,651 (218)

Destabilization of cardiac myosin acetylation and sequestration with type 2 diabetes mellitus. [PDF]

Cardiovasc Diabetol
Degezelle MM, Chaami C, Lewis CTA, Zhang C, Hessel AL, Rainer PP, Kirk JA, Stokke MK, Seaborne RAE, Ochala J.   +9 more
europepmc   +1 more source

Expanding the scope of SGLT inhibitors in underrepresented cardiac populations: from pathophysiology to clinical evidence. [PDF]

Front Cardiovasc Med
Padda B, Kelleher JT, Muroke V, Sridhar VS, Tremblay-Gravel M, Tardif JC, Boulet J.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Cryo-EM structure of the human cardiac myosin filament

Nature, 2023
Debabrata Dutta, Kenneth S Campbell, Raúl Padron   +2 more
exaly  

Restoration of Cardiac Myosin Light Chain Kinase Ameliorates Systolic Dysfunction by Reducing Superrelaxed Myosin

Circulation, 2023
Osamu Tsukamoto, Ken Matsuoka, Junjun Li   +2 more
exaly  

Cardiac myosin-specific autoimmune T cells contribute to immune-checkpoint-inhibitor-associated myocarditis

Cell Reports, 2022
Taejoon Won, Mónica V Talor, Ninaad Lasrado   +2 more
exaly  

Deciphering the super relaxed state of human β-cardiac myosin and the mode of action of mavacamten from myosin molecules to muscle fibers

Proceedings of the National Academy of Sciences of the United States of America, 2018
Darshan V Trivedi, Saswata S Sarkar, Weikang Ma   +2 more
exaly  

Development of clinically viable non-muscle myosin II small molecule inhibitors

Cell
Madalyn Hafenbreidel, Courtney A Miller
exaly  

The Efficacy of Cardiac Myosin Inhibitors Versus Placebo in Patients With Symptomatic Hypertrophic Cardiomyopathy: A Meta-Analysis and Systematic Review

American Journal of Cardiology
Khalid Changal, Samer J Khouri, George V Moukarbel   +2 more
exaly  

Mavacamten stabilizes an autoinhibited state of two-headed cardiac myosin

Proceedings of the National Academy of Sciences of the United States of America, 2018
John A Rohde, Osha Roopnarine, David D Thomas   +2 more
exaly